What does Exothera do?
EXOTHERA specializes in developing innovative therapies for the treatment of various diseases, particularly focusing on immunotherapy solutions. The company leverages advanced technology and scientific research to create effective treatment options that enhance patient outcomes. Their commitment to excellence in biomedicine drives their continuous pursuit of groundbreaking therapeutic advancements.
- Sectors
- Forestry companies
- Activities
- Signals
-
Juridical warningJuridical warning
The legal status points to elevated risk (e.g. dissolution or bankruptcy).
Reporting lossesReporting losses € -30.01MThe company reported a loss in the latest financial year.
Poor liquidityPoor liquidity 0.43The current ratio is below 1: may be insufficient to cover short-term debt.
Negative cashflowNegative cashflow € -26.97MOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -25.63MEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 4.64MStrong equity provides a buffer against setbacks.
High turnoverHigh turnover € 9.95MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 16.0%Social debts stay manageable relative to personnel costs.
- Shareholders
- Univercells 100%
Financial ratios
|
|
2023
|
2022
|
2021
|
|---|---|---|---|
|
€
9.95M
|
€
7.14M
|
€
4.17M
|
|
|
€
-25.63M
|
€
-19.98M
|
€
-10.29M
|
|
|
€
-31.35M
|
€
-22.98M
|
€
-11.41M
|
|
|
€
4.64M
|
€
3.80M
|
€
2.79M
|
|
|
13.02%
|
13.03%
|
13.39%
|
|
|
€
31.01M
|
€
25.35M
|
€
18.02M
|
|
|
€
2.31M
|
€
1.78M
|
€
727K
|
|
|
146.80
|
130.80
|
97.00
|
Publications 14
All publications- Demissions, Nominations 19/07/2024
- Capital, Actions - Demissions, Nominations 22/02/2024
- Demissions, Nominations 18/09/2023
- Capital, Actions 12/09/2023
- Capital, Actions 22/11/2022
Frequently asked questions
Answers to the most common questions about Exothera, based on official government data and the filed annual accounts.
What is the VAT number of Exothera?
The VAT number of Exothera is BE0744.643.660.
How many employees work at Exothera?
In 2023, Exothera employed 146.80 full-time equivalents (FTE).
When was Exothera established?
Exothera was founded in 02-03-2020.
What is the official address of Exothera?
The official address of Exothera is Zoning De Jumet,Avenue Centrale 52 Charleroi 6040.
What is the legal form of Exothera?
The juridical form of Exothera is Public limited company (NV/SA).
What is the annual revenue of Exothera?
The revenue of Exothera for the 2023 financial year was €9,954,953.
What does Exothera do?
EXOTHERA specializes in developing innovative therapies for the treatment of various diseases, particularly focusing on immunotherapy solutions. The company leverages advanced technology and scientific research to create effective treatment options that enhance patient outcomes. Their commitment to excellence in biomedicine drives their continuous pursuit of groundbreaking therapeutic advancements.
Is Exothera a reliable company?
Exothera is a registered Rechtspersoon with company number 0744.643.660 and can be verified through the official CBE database.
What is the credit limit of Exothera?
The estimated credit limit of Exothera is €404,222.
Is Exothera still active?
Exothera currently has the status "Opening faillissement" and is not active.